Effects of intragastrically administered Pycnogenol® on NNK metabolism in F344 rats

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 2095-2099

  Huynh, H T ^a   Teel, R W ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprevention; NNK; Phytochemicals; Pycnogenol

Indexed keywords

CYTOCHROME P450; FLAVONOID; NITROSAMINE; PYCNOGENOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; HYDROXYLATION; INTRAGASTRIC DRUG ADMINISTRATION; LIVER METABOLISM; LIVER MICROSOME; LUNG; MALE; METABOLISM; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

EID: 0032815117     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Amin S, Desai D, Hecht SS, and Hoffmann D: Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays. Crit Rev Toxicol 26: 139-147, 1996.
2. Villard PH, Seree EM, Re JL, De Meo M, Barra Y, Attolini L, Dumenil G, Catalin J, Durand A, and Lacarelle B: Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp1e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA. Toxic Appl Pharmacol 148: 195-204, 1998.
3. Bouchardy C, Benhamon S, and Dayer P: The effect of tobacco on lung cancer risk depends on CYP 2D6 activity. Cancer Res 56: 251-253, 1996.
4. Smith TJ, Stoner GD, and Yang CS: Activation of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1- butanone (NNK) in human lung microsomes by cytochrome P450, lipoxygenase, and hydroperoxides. Cancer Res 55: 5566-5573, 1995.
5. Guo Z., Smith TJ, Ishizaki H, and Yang CS: Metabolism of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone (NNK) by cytochrome P450 2B1 in a reconstituted system. Carcinogenesis 12: 2277-2282, 1991.
6. Jorquera R, Castonguay A, and Schuller HM: Effect of tobacco smoke condensate on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes. Drug Metab Disp 21: 318-324, 1993.
7. Hecht SS, Carmella SG, Foiles PG, and Murphy SE: Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines. Cancer Res 54(7 Suppl): 1912s-1917s, 1994.
8. Hecht SS: Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. Crit Rev Toxicol 26: 163-181, 1996.
9. Shi ST, Wang ZY, Smith TJ, Hong JY, Chen WF, Ho CT, and Yang CS: Effects of green tea and black tea on 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Res 54; 4641-4647, 1994.
10. Stavric B: Role of chemopreventers in human diet. Clin Biochem 27: 319-332, 1994.
11. Chung FL, Morse MA, Eklind KI, and Xu Y: Inhibition of the tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea. Ann NY Acad Sci 686: 186-201, 1993.
12. Rong Y, Li L, Shah V, and Lau BHS: Pycnogenol protects vascular endothelial cells from t- butyl hydroperoxide induced oxidant injury. Biotech Therap 5: 117-126, 1994.
13. Passwater RA and Kandaswami C: Pycnogenol: the super "protector" nutrient. Connecticut: Keats Publishing, pp. 7-15, 1994.
14. Poli G: Liver damage due to free radicals; in "Free Radicals in Medicine", Cheeseman KH and Slater TF (eds.). Brit Med Bull 49: 604-620, 1993.
15. Nohl H: Involvement of free radicals in aging: a consequence or cause of senescence; in "Free Radicals in Medicine", Cheeseman KH and Slater TF (eds.). Brit Med Bull 49: 653-667, 1993.
16. Ward J: Free radicals, antioxidants and preventive geriatrics. Aust Fam Phys 23: 1297-1301, 1305, 1994.
17. Estabrook RW: The remarkable P450s: a historical overview of these versatile hemeprotein catalysts. FASEB J 10: 202-204, 1996.
18. Cavinenc-Lavier M-C, Bentejac M, Miller M-L, Leclerc J, Siess M-H, Latruffe N, and Suschetet M: Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver. Toxicol Appl Pharm 136: 348-353, 1996.
19. Siess M-H, Ledere J, Canivenc-Lavier M-C, Rat P, and Suschetet M: Heterogenous effects of natural flavonoids on monooxygenase activities in human and rat liver microsomes. Toxicol Appl Pharm 130: 73-78, 1995.
20. Huynh HT and Teel RW: Effects of Pycnogenol® on O-dealkylation by microsomal cytochrome P450 enzymes from rat lung and liver. Pharm Rev Comm 10: 111-117, 1998.
21. Huynh HT and Teel RW: Effects of Pycnogenol® on microsomal metabolism of the tobacco- specific nitrosamine NNK as a function of age. Cancer Lett 132: 135-139, 1998.
22. Peterson LA, Mathew R and Hecht SS: Quantitation of microsomal α-hydroxylation of the tobacco-specific nitrosamine 4-(methylnitrosamino)- 1 -(3 -pyridyl)- 1 -butanone. Carcinogenesis 12: 2069-2072, 1991.
23. Maron DM and Ames BN; Revised methods for the Salmonella mutagenicity test. Mutat Res 113: 173-215, 1983.
24. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 192: 265-275, 1951.
25. Markham KR and Bloor SJ: Analysis and identification of flavonoids in practice. In "Flavonoids in Health and Disease", Rice-Evans CA and Packer L (eds.), New York: Marcel Dekker Inc., pp. 1-33, 1998.
26. Chung FL, Wang M, and Hecht SS: Effects of dietary indoles and isothiocyanates on N- nitrosodimethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone α-hydroxylation and DNA methylation in rat liver. Carcinogenesis 6: 539-543, 1985.
27. Staretz ME, Koenig LA, and Hecht SS: Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl )-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 18: 1715-1722, 1997.
28. Hong JY, Wang ZY, Smith TJ, Zhou S, Shi S, Pan J, and Yang CS: Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4- (methyl-nitrosamino)-1-(3-pyridyl)-1butanone (NNK) in A/J mouse lung. Carcinogenesis 13: 901-904, 1992.
29. Morse MA and Toburen AL: Inhibition of metabolic activation of 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone by limonene. Cancer Lett 104: 211-217, 1996.
30. Zhang Z, Huynh HT, and Teel RW: Effects of orally administered capsaicin, the principal component of Capsicum fruits, on the in vitro metabolism of tobacco-specific nitrosamine NNK in hamster lung and liver microsomes. Anticancer Res 17: 1093-1098, 1997.
31. Masqueller J: Plant extract with a proanthocyamdms content as therapeutic agent havmg radical scavenger effect and use thereof U.S. Patent no. 4, 698, 360, 1987.
32. Nelson AB, Lau BHS, Ide N, and Rong Y: Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage. Drug Dev Indust Pharm 24: 139-144, 1998.
33. Wei ZH, Peng QL, and Lau BHS: Pycnogenol enhances endothelial cell antioxidant defenses. Redox Report 3: 219-224, 1997.
34. Hecht SS, Yang R, and Chen CB: Metabolism in the F344 rat of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. Cancer Res 40: 4144-4150, 1980.